Cardioipins (CLs) are unique tetra-acylated phospholipids of mitochondria and define the bioenergetics and regulatory functions of these organelles. An unresolved paradox is the high uniformity of CL molecular species (tetra-linoleoyl-CL) in the heart, liver, and skeletal muscles-in contrast to their high diversification in the brain. Here, we combined liquid chromatography-mass-spectrometry-based phospholipidomics with genetic and nutritional manipulations to explore CLs' biosynthetic vs postsynthetic remodeling processes in S. cerevisiae yeast cells. By applying the differential phospholipidomics analysis, we evaluated the contribution of Cld1 (CL-specific phospholipase A) and Taz1 (acyl-transferase) as the major regulatory mechanisms of the remodeling process. We further established that nutritional "pressure" by high levels of free fatty acids triggered a massive synthesis of homoacylated molecular species in all classes of phospholipids, resulting in the preponderance of the respective homoacylated CLs. We found that changes in molecular speciation of CLs induced by exogenous C18-fatty acids (C18:1 and C18:2) in wild-type (wt) cells did not occur in any of the remodeling mutant cells, including cld1Δ, taz1Δ, and cld1Δtaz1Δ. Interestingly, molecular speciation of CLs in wt and double mutant cells cld1Δtaz1Δ was markedly different. Given that the bioenergetics functions are preserved in the double mutant, this suggests that the accumulated MLCL-rather than the changed CL speciation-are the likely major contributors to the mitochondrial dysfunction in taz1Δ mutant cells (also characteristic of Barth syndrome). Biochemical studies of Cld1 specificity and computer modeling confirmed the hydrolytic selectivity of the enzyme toward C16-CL substrates and the preservation of C18:1-containing CL species.
pan class="Chemical">Cardioipinsn> (CLs) are unique tetra-acylated phospholipids of mitochondria and define the bioenergetics and regulatory functions of these organelles. An unresolved paradox is the high uniformity of CL molecular species (tetra-linoleoyl-CL) in the heart, liver, and skeletal muscles-in contrast to their high diversification in the brain. Here, we combined liquid chromatography-mass-spectrometry-based phospholipidomics with genetic and nutritional manipulations to explore CLs' biosynthetic vs postsynthetic remodeling processes in S. cerevisiaeyeast cells. By applying the differential phospholipidomics analysis, we evaluated the contribution of Cld1 (CL-specific phospholipase A) and Taz1 (acyl-transferase) as the major regulatory mechanisms of the remodeling process. We further established that nutritional "pressure" by high levels of free fatty acids triggered a massive synthesis of homoacylated molecular species in all classes of phospholipids, resulting in the preponderance of the respective homoacylated CLs. We found that changes in molecular speciation of CLs induced by exogenous C18-fatty acids (C18:1 and C18:2) in wild-type (wt) cells did not occur in any of the remodeling mutant cells, including cld1Δ, taz1Δ, and cld1Δtaz1Δ. Interestingly, molecular speciation of CLs in wt and double mutant cells cld1Δtaz1Δ was markedly different. Given that the bioenergetics functions are preserved in the double mutant, this suggests that the accumulated MLCL-rather than the changed CL speciation-are the likely major contributors to the mitochondrial dysfunction in taz1Δ mutant cells (also characteristic of Barth syndrome). Biochemical studies of Cld1 specificity and computer modeling confirmed the hydrolytic selectivity of the enzyme toward C16-CL substrates and the preservation of C18:1-containing CL species.
Authors: Peter G Barth; Fredoen Valianpour; Valerie M Bowen; Jan Lam; Marinus Duran; Frédéric M Vaz; Ronald J A Wanders Journal: Am J Med Genet A Date: 2004-05-01 Impact factor: 2.802
Authors: Gerhard Liebisch; Juan Antonio Vizcaíno; Harald Köfeler; Martin Trötzmüller; William J Griffiths; Gerd Schmitz; Friedrich Spener; Michael J O Wakelam Journal: J Lipid Res Date: 2013-04-02 Impact factor: 5.922
Authors: Yan Huang; Corey Powers; Satish K Madala; Kenneth D Greis; Wendy D Haffey; Jeffrey A Towbin; Enkhsaikhan Purevjav; Sabzali Javadov; Arnold W Strauss; Zaza Khuchua Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: Yulia Y Tyurina; Samuel M Poloyac; Vladimir A Tyurin; Alexander A Kapralov; Jianfei Jiang; Tamil Selvan Anthonymuthu; Valentina I Kapralova; Anna S Vikulina; Mi-Yeon Jung; Michael W Epperly; Dariush Mohammadyani; Judith Klein-Seetharaman; Travis C Jackson; Patrick M Kochanek; Bruce R Pitt; Joel S Greenberger; Yury A Vladimirov; Hülya Bayır; Valerian E Kagan Journal: Nat Chem Date: 2014-04-20 Impact factor: 24.427
Authors: Yang Xu; Murari Anjaneyulu; Alec Donelian; Wenxi Yu; Miriam L Greenberg; Mindong Ren; Edward Owusu-Ansah; Michael Schlame Journal: Proc Natl Acad Sci U S A Date: 2019-05-20 Impact factor: 11.205
Authors: Wenjia Lou; Hsiu-Chi Ting; Christian A Reynolds; Yulia Y Tyurina; Vladimir A Tyurin; Yiran Li; Jiajia Ji; Wenxi Yu; Zhuqing Liang; Detcho A Stoyanovsky; Tamil S Anthonymuthu; Michael A Frasso; Peter Wipf; Joel S Greenberger; Hülya Bayır; Valerian E Kagan; Miriam L Greenberg Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2018-06-20 Impact factor: 4.698
Authors: Honglu Chao; Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew A Amoscato; Laura K Cole; Grant M Hatch; Jing Ji; Valerian E Kagan; Hülya Bayır Journal: JCI Insight Date: 2018-11-02
Authors: Marcus Conrad; Valerian E Kagan; Hülya Bayir; Gabriela C Pagnussat; Brian Head; Maret G Traber; Brent R Stockwell Journal: Genes Dev Date: 2018-05-01 Impact factor: 11.361
Authors: María Lairón-Peris; Gabriel L Castiglioni; Sarah J Routledge; Javier Alonso-Del-Real; John A Linney; Andrew R Pitt; Josef Melcr; Alan D Goddard; Eladio Barrio; Amparo Querol Journal: Microb Genom Date: 2021-08